Lynch syndrome
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Included cases were investigated by Lynch syndrome screening test between May 1 of 2005 and March 31 of 2019. Results of MMR immunohistochemistry and MSI tests were adequately archived in the medical records.
Exclusion criteria
Exclusion criteria: Analysis of MMR immunohistochemistry and/or MSI tests were inadequate, or the imformation of those tests were not sufficiently archived in the medical records.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concordance of MMR immunohistochemistry and MSI test. | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Relationship between the germline mutation status and MMR/MSI tests. (2) Analysis of disconcordance case between MMR and MSI tests. | — |
Countries
Japan
Contacts
The Cancer Institute Hospital of Japanese Foundation for Cancer Research Department of Pathology